S
ABEO icon

SignatureFD’s Abeona Therapeutics ABEO Stock Holding History

SignatureFD’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-687
Closed -$3.63K – 3406
2025
Q3 		$3.63K Buy
687
+512
+293% +$3.25K ﹤0.01% 2779
2025
Q2 		$994 Buy
+175
New +$996 ﹤0.01% 3026
2020
Q2 		– Hold
0
– – – 2472
2020
Q1 		– Hold
0
– – – 2270
2019
Q4 		– Hold
0
– – – 2171
2019
Q3 		– Hold
0
– – – 2084
2019
Q2 		– Hold
0
– – – 2016
2019
Q1 		– Hold
0
– – – 1953
2018
Q4 		– Hold
0
– – – 1922
2018
Q3 		– Hold
0
– – – 1899
2018
Q2 		– Hold
0
– – – 1899
2018
Q1 		– Hold
0
– – – 1732

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

SignatureFD's ABEO Position: Q4 2025 in Review

SignatureFD sold out of Abeona Therapeutics (ABEO) in Q4 2025, closing a stake of 687 shares — an estimated $3.63K sold.

SignatureFD first reported a position in ABEO in Q2 2025 and held it in 2 quarters. The position peaked at $3.63K in Q3 2025. 104 funds tracked by Wall St. Rank hold ABEO as of Q4 2025.

  • SignatureFD reported no remaining Abeona Therapeutics position as of Q4 2025 after selling out during the quarter.
  • SignatureFD sold 687 Abeona Therapeutics shares in Q4 2025, an estimated $3.63K.
  • SignatureFD first reported a position in Abeona Therapeutics in Q2 2025 and held it in 2 quarters.
  • SignatureFD's Abeona Therapeutics position peaked at $3.63K in Q3 2025.
  • 104 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2025.

Based on SignatureFD's 13F filing for Q4 2025, filed 20 Jan 2026.